Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.

@article{CamposVarela2015AdvancesIT,
  title={Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.},
  author={Isabel Campos-Varela and Marion G. Peters and Norah A. Terrault},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2015},
  volume={60 1},
  pages={108-16}
}
Complications of cirrhosis due to hepatitis C virus (HCV) are increasing, and liver transplantation (LT) is the most effective treatment for those with liver decompensation or small hepatocellular carcinoma. However, for patients with human immunodeficiency virus (HIV) coinfection, barriers to LT exist. This is related to the poorer survival rates post-LT (55% at 5 years) and, up until this year, the limited options for treating those coinfected LT recipients with progressive recurrent HCV… CONTINUE READING